CRC
GILD icon

Curi RMB Capital’s Gilead Sciences GILD Stock Holding History

Curi RMB Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4M Sell
74,630
-12,679
-15% -$1.78M 0.19% 138
2025
Q4 		$10.7M Sell
87,309
-874
-1% -$106K 0.19% 133
2025
Q3 		$9.79M Sell
88,183
-15,707
-15% -$1.79M 0.18% 145
2025
Q2 		$11.5M Buy
103,890
+24,313
+31% +$2.59M 0.22% 124
2025
Q1 		$8.92M Sell
79,577
-4,947
-6% -$510K 0.22% 135
2024
Q4 		$7.81M Sell
84,524
-3,326
-4% -$299K 0.18% 156
2024
Q3 		$7.37M Buy
87,850
+805
+0.9% +$61.4K 0.17% 161
2024
Q2 		$5.97M Buy
87,045
+1,752
+2% +$117K 0.14% 169
2024
Q1 		$6.25M Buy
85,293
+6,275
+8% +$483K 0.14% 170
2023
Q4 		$6.4M Buy
79,018
+11,821
+18% +$920K 0.2% 132
2023
Q3 		$5.04M Buy
67,197
+1,589
+2% +$122K 0.17% 136
2023
Q2 		$5.06M Buy
65,608
+4,251
+7% +$339K 0.17% 136
2023
Q1 		$5.09M Buy
61,357
+14,257
+30% +$1.18M 0.18% 132
2022
Q4 		$4.04M Buy
47,100
+11,266
+31% +$892K 0.14% 154
2022
Q3 		$2.21M Buy
35,834
+18,537
+107% +$1.17M 0.08% 216
2022
Q2 		$1.07M Buy
17,297
+8,351
+93% +$517K 0.04% 274
2022
Q1 		$532K Sell
8,946
-29
-0.3% -$1.85K 0.02% 324
2021
Q4 		$652K Sell
8,975
-21
-0.2% -$1.45K 0.02% 332
2021
Q3 		$628K Buy
8,996
+29
+0.3% +$2.04K 0.02% 324
2021
Q2 		$617K Hold
8,967
– – 0.02% 334
2021
Q1 		$580K Sell
8,967
-33
-0.4% -$2.13K 0.02% 337
2020
Q4 		$524K Sell
9,000
-317
-3% -$19.1K 0.02% 422
2020
Q3 		$589K Sell
9,317
-42
-0.4% -$2.91K 0.03% 395
2020
Q2 		$720K Sell
9,359
-9,608
-51% -$736K 0.03% 352
2020
Q1 		$1.42M Buy
18,967
+9,584
+102% +$662K 0.07% 237
2019
Q4 		$610K Sell
9,383
-620
-6% -$40.4K 0.02% 422
2019
Q3 		$634K Sell
10,003
-542
-5% -$35.4K 0.02% 455
2019
Q2 		$712K Sell
10,545
-7,267
-41% -$478K 0.02% 478
2019
Q1 		$1.16M Sell
17,812
-2,021
-10% -$134K 0.03% 428
2018
Q4 		$1.24M Sell
19,833
-135
-0.7% -$9.44K 0.03% 456
2018
Q3 		$1.54M Sell
19,968
-4
-0% -$302 0.04% 433
2018
Q2 		$1.42M Sell
19,972
-34,632
-63% -$2.45M 0.03% 439
2018
Q1 		$4.12M Buy
54,604
+3,826
+8% +$304K 0.11% 254
2017
Q4 		$3.64M Sell
50,778
-3,674
-7% -$279K 0.09% 284
2017
Q3 		$4.41M Buy
54,452
+34,724
+176% +$2.66M 0.11% 253
2017
Q2 		$1.4M Buy
19,728
+698
+4% +$46.4K 0.04% 403
2017
Q1 		$1.29M Buy
19,030
+335
+2% +$23.6K 0.05% 270
2016
Q4 		$1.34M Buy
18,695
+15,912
+572% +$1.18M 0.07% 218
2016
Q3 		$220K Sell
2,783
-87
-3% -$7.07K 0.01% 378
2016
Q2 		$239K Buy
+2,870
New +$255K 0.01% 382

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Curi RMB Capital's GILD Position: Q1 2026 in Review

Curi RMB Capital reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $1.78M and leaving 74,630 shares worth $10.4M. The position accounts for 0.19% of the portfolio, ranked #138.

Curi RMB Capital first reported a position in GILD in Q2 2016 and has held it in 40 quarters since. The position peaked at $11.5M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Curi RMB Capital held 74,630 shares of Gilead Sciences worth $10.4M as of Q1 2026.
  • Curi RMB Capital sold 12,679 Gilead Sciences shares in Q1 2026, an estimated $1.78M.
  • Gilead Sciences made up 0.19% of Curi RMB Capital's portfolio in Q1 2026, its #138 holding.
  • Curi RMB Capital first reported a position in Gilead Sciences in Q2 2016 and has held it in 40 quarters since.
  • Curi RMB Capital's Gilead Sciences position peaked at $11.5M in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.